commercial weight loss programs

Recession Is Coming – But Commercial Diet Companies Could Benefit

March 13, 2025 Marketdata, the parent company of DietBusinessWatch.com, is currently updating its report on the Commercial & Retail Weight Loss Market. Several things have become apparent as we do the research Marketdata analysts see a possible opportunity this year for the commercial (non-medical) weight loss firms to recover some ground. Here’s how we think […]

Recession Is Coming – But Commercial Diet Companies Could Benefit Read More »

GLP-1 Drugs Are Affecting Consumers’ Food Spending Habits

News / John LaRosa

March 5, 2025 Weight loss drugs (GLP-1s) have soared in popularity over the last two years, with about 12% of American adults reporting that they’ve used a medication like Ozempic, Wegovy or Mounjaro to slim down. That’s a big slice of the population — and new research shows that being on these medications influences what

GLP-1 Drugs Are Affecting Consumers’ Food Spending Habits Read More »

$33 Billion U.S. Medical Weight Loss Market Dominated by GLP-1 Drugs – New Report

News / John LaRosa

Feb. 27, 2025 Marketdata LLC has published anew 154-page analysis of the U.S. weight loss market, entitled: “The U.S. Medical Weight Loss Market: The Impact of GLP-1 Drugs on Doctors, Hospitals, Clinics and Franchises”, February 2025. This report presents a complete picture of the medical weight loss market in the United States, with the inter-relationships between competing

$33 Billion U.S. Medical Weight Loss Market Dominated by GLP-1 Drugs – New Report Read More »

Herbalife Reports 2024 Results, $567 Million Weight Loss U.S. Sales

News / John LaRosa

Feb. 2o, 2025 Herbalife reported Q4 and full year 2024 results. The company sells a significant amount of weight loss and meal replacement products each year. “With three consecutive quarters of new distributor growth, a new incoming CEO and significantly improved Adjusted EBITDA2 margins, we enter 2025 with strong momentum.” – Michael Johnson, Chairman and

Herbalife Reports 2024 Results, $567 Million Weight Loss U.S. Sales Read More »

Telehealth Weight Loss Market Worth $6.9 Billion And Growing

News / John LaRosa

April 13, 2024 Marketdata LLC (parent company of DietBusinessWatch) has just released new research, a report entitled: “The Telehealth Weight Loss Market”. The market for weight loss programs delivered via telehealth / telemedicine companies is worth $6.9 billion, and growing. Telehealth soared during the pandemic in 2020 as consumers stayed home and communicated with their

Telehealth Weight Loss Market Worth $6.9 Billion And Growing Read More »

U.S. Weight Loss Market Worth $90 Billion, Boosted by Diet Drugs

News / John LaRosa

March 4, 2024 U.S. Weight Loss Market Now Worth $90 Billion, Obesity Drug Sales Soar March 4, 2024 Marketdata LLC has just published a new analysis of the weight loss market: “The U.S. Weight Loss Market: 2024 Status Report & Forecast”, March 2024, 107 Pages Some findings: The total U.S. weight loss market is estimated

U.S. Weight Loss Market Worth $90 Billion, Boosted by Diet Drugs Read More »

(813) 971-8080

Recession Is Coming – But Commercial Diet Companies Could Benefit

GLP-1 Drugs Are Affecting Consumers’ Food Spending Habits

$33 Billion U.S. Medical Weight Loss Market Dominated by GLP-1 Drugs – New Report

Herbalife Reports 2024 Results, $567 Million Weight Loss U.S. Sales

Telehealth Weight Loss Market Worth $6.9 Billion And Growing

U.S. Weight Loss Market Worth $90 Billion, Boosted by Diet Drugs